1 Reason I Wouldn’t Buy Centrica PLC Today

Royston Wild explains why nuclear problems at Centrica PLC (LON: CNA) should crimp group profits still further.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Today I am looking at why more upstream issues will dent Centrica’s (LSE: CNA) already-patchy earnings outlook.

Nuclear blowout hampers the bottom line

Centrica’s embattled upstream operations received a further blow last week when fellow energy giant EDF Energyannounced that it would be shuttering nuclear reactors at its Heysham 1 and Hartlepool power stations. Centrica owns a 20% stake in the French firm’s nuclear operations, so production problems here could have a sizeable impact on its own bottom line.

EDF Energy commented that a boiler spine defect had been discovered during standard inspections at Heysham 1in June, a scenario which ngthreatens a prolonged production blackout.

Indeed, the business advised that “until the results of the further inspections are known it is not possible to advise exact return to service dates for these four reactors,” and went on to comment that”an initial estimate is that these investigations will take around eight weeks”.

Centrica warned that this impact on its nuclear output is likely to harm earnings this year to the tune of 0.3p per share. But the question of when these investigations are likely to conclude — not to mention the extent of potential repair work as well as timing on when the plants will be back up to full capacity — could prompt a detrimental revision to these current earnings estimates.

The suspension also highlighted the creaking state of Britain’s nuclear fleet, and Centrica should not be surprised if similar problems spring up in the near future — its holding in EDF’s atomic energy business is spread across all eight of the French company’s UK nuclear stations.

Centrica’s nuclear exposure has been one of the few bright spots for its flailing upstream operations in recent times, and the impact of weak commodity prices drove operating profit at Centrica Energy more than a third lower to £526m during the 12 months ending June 2014. In this context a 2% uptick in operating profit from its nuclear sub-division, to £125m, can be viewed as a success, making last week’s news an even more bitter pill to swallow.

With Centrica also facing huge problems at its downstream operations through rising regulatory pressure and increased competition, this fresh problem adds another problem to the energy firm’s already-substantial list.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any shares mentioned. The Motley Fool has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »